Hydroxycarteolol
From Wikipedia, the free encyclopedia
![]() |
|
Clinical data | |
---|---|
ATC code | None |
Identifiers | |
|
|
Synonyms | 8-Hydroxycarteolol |
CAS Number | 59826-22-1 |
PubChem (CID) | 124688 |
ChemSpider | 111020 |
Chemical and physical data | |
Formula | C16H24N2O4 |
Molar mass | 308.37 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
Hydroxycarteolol is a beta blocker and metabolite of carteolol.[1][2]
References[edit]
- ^ Igarashi H, Katsuta Y, Sawa K, Nakazato Y, Kawasaki T (Apr 1990). "A comparison of the opacifying effects of carteolol.HCl and 8-hydroxycarteolol.HCl in the isolated porcine cornea". Fundam Appl Toxicol. 14 (3): 554–559. doi:10.1093/toxsci/14.3.554. PMID 2340982.
- ^ Jasper JR, Michel MC, Insel PA (1990). "The beta-adrenoceptor antagonist carteolol and its metabolite 8-hydroxycarteolol have different intrinsic sympathomimetic activities". Br J Clin Pharmacol. 30 (Suppl 1): 109S–111S. doi:10.1111/j.1365-2125.1990.tb05477.x. PMC 1368107
. PMID 2176514.
![]() |
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |